$Grifols (GRFS.US)$ today announced positive topline results...
$Grifols(GRFS.US$ today announced positive topline results from AdFirst phase 3 study confirming the efficacy of fibrinogen concentrate in reducing intraoperative blood loss.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment